During the past decade, Hosp Cardiology Haut Leveque - Dept Congenital Diseases conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hosp Cardiology Haut Leveque - Dept Congenital Diseases" are "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "Hosp Cardiology Haut Leveque - Dept Congenital Diseases" in a lesser frequency.

Most popular intervention types in "Hosp Cardiology Haut Leveque - Dept Congenital Diseases" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Macitentan 10 mg" (1 trials), "Macitentan 10 mg tablet, once daily." (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hosp Cardiology Haut Leveque - Dept Congenital Diseases" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hosp Cardiology Haut Leveque - Dept Congenital Diseases". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hosp Cardiology Haut Leveque - Dept Congenital Diseases, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hosp Cardiology Haut Leveque - Dept Congenital Diseases, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".